Traws Pharma advances antiviral program for hantavirus and ebola outbreaks

Go back to Traws Pharma advances antiviral program for hantavirus and ebola outbreaks
(NASDAQ: TRAW) Delayed: 0.86 +0.01 (1.18%)
Previous Close $0.85    52 Week High
Open $0.84    52 Week Low
Day High $0.86    P/E N/A 
Day Low $0.81    EPS
Volume 53,665